Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Radiation in Biopsy-only Glioblastoma
NCT01100177Phase 2Completed
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Start
- Jun 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in glioblastoma (GBM), sponsored by Grupo Español de Investigación en Neurooncología. Started Jun 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01100177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100177.